FDA grants priority review to Salix treatment
RALEIGH, N.C. (AP) — Salix Pharmaceuticals Ltd. said Tuesday that the Food and Drug Administration granted a priority review to its potential treatment for HIV-associated diarrhea.
The Raleigh, N.C., company had submitted the oral treatment, crofelemer, to regulators for review in December. A priority review is given to drugs that may offer treatment advances or provide a treatment where no adequate therapy exis...
You have selected to view an article that is older than 60 days. There are several ways to unlock access to NewsOK historical content.
Please sign in. (You might already have access)
If you are a print subscriber to The Oklahoman, activate your Digital Pass for free access.
Purchase any of The Oklahoman's digital products (digital replica, archives, iPad and smartphone apps), and access to historical NewsOK content is free.
Please sign in. (You might already have access)
If you are a print subscriber to The Oklahoman, activate your Digital Pass for free access.
Purchase any of The Oklahoman's digital products (digital replica, archives, iPad and smartphone apps), and access to historical NewsOK content is free.
